Vela Laboratories, a provider of analytical services to the global biopharmaceutical industry, today announced the renewal of the GMP certificate for its analytical and Quality Control laboratories until 2013.
"We are pleased that Vela Laboratories has its GMP certification renewed, as this achievement will further strengthen our position as a provider to the global pharmaceutical and biotechnology industry," said Dr. Markus Fido, co-founder and CEO of Vela Laboratories. "Vela has established a broad analytical method portfolio, serving the needs of manufacturers of Biopharmaceuticals and Biosimilars in Europe, North America, and India, including the characterization of complex proteins like monoclonal antibodies or growth factors."
"The fact that no findings were made during the inspection demonstrates that our whole team is dedicated to the highest quality standards," said Dr. Andreas Nechansky, co-founder and COO of Vela Laboratories. "The renewal of the GMP certification for our analytical and Quality Control laboratories confirms that we are on the right track towards our goal of becoming a major player in the analytical services business."
'Good Manufacturing Practice' is a body of internationally accepted regulations set forth by EU and US drug agencies. GMP compliance ensures that pharmaceuticals, active ingredients and medical devices are produced and quality-controlled according to state-of-the-art standards. GMP compliance is the gold standard in quality for the life sciences industry.
Freezing Point Osmometry in Life Science Applications